Oncos Therapeutics develops next generation oncolytic viruses into cancer therapeutics.

Since the start of our Advanced Therapy Access Program, over 200 patients have undergone treatment with our viruses, suggesting strong safety and efficacy. The Program is based on extensive scientific research at Helsinki University and elsewhere.

The contributors include people working at and for Oncos Therapeutics, and the selected guest writers in science and biotechnology business.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: